WASHINGTON, May 25 / BNA / Pfizer Inc. said, on Wednesday, that it will provide nearly two dozen products, including the best-selling COVID-19 vaccine and treatment, at non-profit prices in some of the world’s poorest countries.
The drug company announced the program at the annual meeting of the World Economic Forum in Davos, Switzerland, and said it aims to improve health equity in 45 low-income countries.
“What we’ve found through the pandemic is that the supply hasn’t been enough to solve the problems these countries are facing,” Albert Burla, Pfizer’s president and CEO, said during a talk in Davos.
Most of the countries are located in Africa, but the list also includes Haiti, Syria, Cambodia and North Korea, according to the Associated Press.
Products widely available in the United States and the European Union include 23 drugs and vaccines to treat infectious diseases, some types of cancer, and rare and inflammatory conditions.
Ezell said New York-based Pfizer would only charge “minimum” manufacturing and distribution costs. You will comply with any penalties and all other applicable laws.
The drug company also plans to provide assistance with general education and training for health care providers and to manage drug supply.
Earlier this month, the head of the World Health Organization called on Pfizer to make treatment for COVID-19 more widely available in poor countries.
Comirnaty brought in nearly $37 billion in sales last year, and analysts expect Paxlovid’s treatment for the COVID-19 virus for the company to add nearly $24 billion this year, according to data firm FactSet.